While I totally agree with the Quality Assurance best practices you have mentioned in the article, are they any different from QA practices you would follow for a digital project in another industry, let’s say Insurance or Media? Would like to know your thoughts around how specifically this (or other approaches) can improve effectiveness of pharma digital projects. – JASMEET SAWHNEY
Your brand Is liable
Cases like these are not atypical in today’s world. Pharmaceutical executives need to think about evolving technology and be prepared for the impact when glitches happen. After all, the possibility exists that glitches may represent the same level of liability as a brand recall.
If your digital property is riddled with errors, your target is going to have a suboptimal experience. In other words, defects erode the relationship your target has with your brand.